WordNet

create by mixing or combining
(chemistry) a substance formed by chemical union of two or more elements or ingredients in definite proportion by weight (同)chemical_compound
put or add together; "combine resources" (同)combine
an enclosure of residences and other building (especially in the Orient)
a whole formed by a union of two or more elements or parts
combine so as to form a whole; mix; "compound the ingredients" (同)combine
calculate principal and interest
composed of more than one part; "compound leaves are composed of several lobes; "compound flower heads"
consisting of two or more substances or ingredients or elements or parts; "soap is a compound substance"; "housetop is a compound word"; "a blackberry is a compound fruit"
a unit of force equal to the force exerted by gravity; used to indicate the force to which a body is subjected when it is accelerated (同)gee, g-force
the 7th letter of the Roman alphabet (同)g
combined into or constituting a chemical compound

PrepTutorEJDIC

(…になるように)〈要素・成分など〉'を'混ぜ合わせる《+『名』+『into』+『名』》;(…から)〈薬など〉'を'調合する,混ぜ合わせて作る《+『名』+『from』(『of』)+『名』》 / 《しばしば受動態で》〈めんどうな事・損害など〉'を'もっとひどくする / 〈利子〉'を'複利で計算する / (…と)話し合いをつける,妥協する《+『with』+『名』》 / 複合の,合成の / 『合成物』,混合物,調合物;化合物 / 複合語,合成語(classroom, heart-to-heartなどをいう)
(異民族の家屋・商館などがある)囲み地区,構内

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

PET imaging of cyclooxygenase-2 (COX-2) in a pre-clinical colorectal cancer model.

Tietz O1, Wuest M1, Marshall A1, Glubrecht D1, Hamann I1, Wang M1, Bergman C1, Way JD1, Wuest F2,3.
EJNMMI research.EJNMMI Res.2016 Dec;6(1):37. doi: 10.1186/s13550-016-0192-9. Epub 2016 Apr 26.
BACKGROUND: Cyclooxygenase-2 (COX-2) is the inducible isoform of the cyclooxygenase enzyme family. COX-2 is involved in tumor development and progression, and frequent overexpression of COX-2 in a variety of human cancers has made COX-2 an important drug target for cancer treatment. Non-invasive ima
PMID 27112768

Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors.

Xiao W1, Li T2,3,4, Bononi FC1, Lac D1, Kekessie IA1, Liu Y5, Sanchez E1, Mazloom A1, Ma AH1, Lin J1, Tran J1, Yang K2,6, Lam KS1,2,3, Liu R7,8.
EJNMMI research.EJNMMI Res.2016 Dec;6(1):18. doi: 10.1186/s13550-016-0165-z. Epub 2016 Feb 27.
BACKGROUND: α3β1 integrin is overexpressed in several types of human cancer and is associated with poor prognosis, metastasis, and resistance to cancer treatment. We previously identified a cyclic peptide ligand LXY1 that specifically binds to the α3β1 integrin on human glioblastoma U-87MG cells
PMID 26922417

Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors.

Accardo A1, Galli F2, Mansi R3, Del Pozzo L3, Aurilio M4, Morisco A4, Ringhieri P1, Signore A2, Morelli G1, Aloj L5.
EJNMMI research.EJNMMI Res.2016 Dec;6(1):17. doi: 10.1186/s13550-016-0175-x. Epub 2016 Feb 20.
BACKGROUND: Overexpression of the gastrin-releasing peptide receptor (GRP-R) has been documented in several human neoplasms such as breast, prostate, and ovarian cancer. There is growing interest in developing radiolabeled peptide-based ligands toward these receptors for the purpose of in vivo imagi
PMID 26897133